In these short interviews, Sai Shankar, Adam Shain and Marcus Bates discuss the full potential of connectivity, coronavirus as a potential accelerator of adoption, and the place of connected drug delivery systems within Aptar Pharma’s broader offering to industry.
The interviews review the potential for digital Healthcare and current barriers in its adoption for both chronic and acute treatments and for diagnostic tools. To help overcome the barriers, presenting Real World data can strengthen the business case and illustrate the overall value.
Confinement during Covid 19 has accelerated the increased use of telemedicine as patients were unable to physically visit their doctors, which bodes well for the future of the digital health solutions.
Aptar Pharma is well positioned to deliver digital healthcare solutions to stakeholders, worldwide, with a wide range of therapeutic areas acting as a real integrator and offering customized solutions to meet patients’ needs.